Ohio Attorney General Dave Yost is seeking a lead role in a securities class-action lawsuit accusing the pharmaceutical company GSK, formerly known as GlaxoSmithKline, of concealing the cancer risks of its once-bestselling drug, fueling billions in losses for investors.